Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novanta (NOVT) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Novanta (NOVT) over the last 13 years, with Q3 2025 value amounting to $3.5 million.

  • Novanta's Change in Accured Expenses rose 34341.74% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 5298.85%. This contributed to the annual value of $13.1 million for FY2024, which is 16386.35% up from last year.
  • As of Q3 2025, Novanta's Change in Accured Expenses stood at $3.5 million, which was up 34341.74% from -$5.2 million recorded in Q2 2025.
  • Novanta's 5-year Change in Accured Expenses high stood at $20.4 million for Q3 2022, and its period low was -$22.3 million during Q1 2023.
  • Its 5-year average for Change in Accured Expenses is $2.5 million, with a median of $3.5 million in 2025.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first surged by 47074.07% in 2021, then plummeted by 5857105.26% in 2023.
  • Over the past 5 years, Novanta's Change in Accured Expenses (Quarter) stood at $5.0 million in 2021, then plummeted by 81.22% to $940000.0 in 2022, then skyrocketed by 358.09% to $4.3 million in 2023, then increased by 29.03% to $5.6 million in 2024, then plummeted by 37.44% to $3.5 million in 2025.
  • Its Change in Accured Expenses stands at $3.5 million for Q3 2025, versus -$5.2 million for Q2 2025 and $1.7 million for Q1 2025.